Risk of stroke-Associated pneumonia with acid-suppressive drugs a population-based cohort study

Medicine (United States)

Volumn 94, Issue 29, 2015, Pages

  Ho, Sai Wai ^a   Hsieh, Ming Ju ^b   Yang, Shun Fa ^c   Yeh, Ying Tung ^a   Wang, Yu Hsun ^b   Yeh, Chao Bin ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; CHRONIC LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROSTOMY; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NOSE FEEDING; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; ADOLESCENT; COMPLICATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SOCIOECONOMICS; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROPORTIONAL HAZARDS MODELS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; STROKE; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84942432723     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001227     Document Type: Article

References (33)

1. Ji R, Wang D, Shen H, et al., China National Stroke Registry (CNSR) Investigators. Interrelationship among common medical complications after acute stroke: pneumonia plays an important role. Stroke. 2013;44:3436-3444
2. Vermeij FH, Scholte op Reimer WJ, de Man P, et al., Netherlands Stroke Survey Investigators. Stroke-Associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27:465-471
3. Katzan IL, Dawson NV, Thomas CL, et al. The cost of pneumonia after acute stroke. Neurology. 2007;68:1938-1943
4. Ji R, Shen H, Pan Y, et al., China National Stroke Registry Investigators. Novel risk score to predict pneumonia after acute ischemic stroke. Stroke. 2013;44:1303-1309
5. Li L, Zhang LH, Xu WP, et al. Risk assessment of ischemic stroke associated pneumonia. World J Emerg Med. 2014;5:209-213
6. Harms H, Grittner U, Droge H, et al. Predicting post-stroke pneumonia: the PANTHERIS score. Acta Neurol Scand. 2013;128: 178-184
7. Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54-59
8. Giannella RA, Broitman SA, Zamcheck N. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med. 1973;78:271-276
9. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of communityacquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292:1955-1960
10. Chen CH, Lin HC, Lin HL, et al. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease. J Microbiol Immunol Infect. 2013pii: S1684-1182(13)00198-9. doi: 10.1016/j.jmii.2013.10.004
11. Dublin S, Walker RL, Jackson ML, et al. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study. Pharmacoepidemiol Drug Saf. 2010;19:792-802
12. Ho SW, Tsai MC, Teng YH, et al. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors. BMJ Open. 2014;4:e006710
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383
14. Teramoto S. Novel preventive and therapuetic strategy for poststroke pneumonia. Expert Rev Neurother. 2009;9:1187-1200
15. Walter U, Knoblich R, Steinhagen V, et al. Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol. 2007;254:1323-1329
16. Alsumrain M, Melillo N, Debari VA, et al. Predictors and outcomes of pneumonia in patients with spontaneous intracerebral hemorrhage. J Intensive Care Med. 2013;28:118-123
17. Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975-981
18. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008;7:341-353
19. Herzig SJ, Doughty C, Lahoti S, et al. Acid-suppressive medication use in acute stroke and hospital-Acquired pneumonia. Ann Neurol. 2014;76:712-718
20. Sui R, Zhang L. Risk factors of stroke-Associated pneumonia in Chinese patients. Neurol Res. 2011;33:508-513
21. Lipson DM, Sangha H, Foley NC, et al. Recovery from stroke: differences between subtypes. Int J Rehabil Res. 2005;28:303-308
22. Yeh SJ, Huang KY, Wang TG, et al. Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit. J Neurol Sci. 2011;306:38-41
23. Millns B, Gosney M, Jack CI, et al. Acute stroke predisposes to oral gram-negative bacilli: a cause of aspiration pneumonia? Gerontology. 2003;49:173-176
24. Haeusler KG, Schmidt WU, Fohring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25:50-58
25. Vogelgesang A, Grunwald U, Langner S, et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke. 2008;39:237-241
26. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725-736
27. Chamorro A , Meisel A, Planas AM, et al. The immunology of acute stroke. Nat Rev Neurol. 20125;8:401-410
28. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95:3118-3122
29. Pham CQ, Regal RE, Bostwick TR, et al. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40:1261-1266
30. Scaringi L, Cornacchione P, Fettucciari K, et al. Activity inhibition of cytolytic lymphocytes by omeprazole. Scand J Immunol. 1996;44:204-214
31. Ran L, Khatibi NH, Qin X, et al. Proton pump inhibitor prophylaxis increases the risk of nosocomial pneumonia in patients with an intracerebral hemorrhagic stroke. Acta Neurochir Suppl. 2011;111:435-439
32. Jena AB, Sun E, Goldman DP. Confounding in the association of proton pump inhibitor use with risk of community-Acquired pneumonia. J Gen Intern Med. 2013;28:223-230
33. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-Acquired pneumonia. Ann Intern Med. 2008;149:391-398.